Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
McKesson
Deloitte
Fuji
Mallinckrodt
Teva
Medtronic
AstraZeneca
Cipla
Johnson and Johnson

Generated: January 16, 2018

DrugPatentWatch Database Preview

ARESTOCAINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Arestocaine Hydrochloride, and what generic alternatives are available?

Arestocaine Hydrochloride is a drug marketed by Solvay and is included in two NDAs.

The generic ingredient in ARESTOCAINE HYDROCHLORIDE is levonordefrin; mepivacaine hydrochloride. There are two drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the levonordefrin; mepivacaine hydrochloride profile page.
Summary for ARESTOCAINE HYDROCHLORIDE
Drug patent expirations by year for ARESTOCAINE HYDROCHLORIDE

US Patents and Regulatory Information for ARESTOCAINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Solvay ARESTOCAINE HYDROCHLORIDE mepivacaine hydrochloride INJECTABLE;INJECTION 084777-002 Apr 18, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Solvay ARESTOCAINE HYDROCHLORIDE W/ LEVONORDEFRIN levonordefrin; mepivacaine hydrochloride INJECTABLE;INJECTION 085010-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
US Army
Express Scripts
Fish and Richardson
Citi
Cipla
Baxter
Novartis
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot